Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain

por Sabag, Adi D., Bode, Julia, Fink, Dorit, Kigel, Boaz, Kugler, Wilfried, Neufeld, Gera
Publicado 2012

Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases

por Eiza, Nasren, Kessler, Ofra, Sabag, Adi, Neufeld, Gera, Jones, E. Yvonne, Vadasz, Zahava
Publicado 2023

Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cells

por Toledano, Shira, Sabag, Adi D., Ilan, Neta, Liburkin-Dan, Tanya, Kessler, Ofra, Neufeld, Gera
Publicado 2023

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis

por Bejar, Jacob, Kessler, Ofra, Sabag, Adi D., Sabo, Edmond, Itzhak, Ofer Ben, Neufeld, Gera, Vadasz, Zahava
Publicado 2018

Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients

por Hexner-Erlichman, Zufit, Veiga-da-Cunha, Maria, Zehavi, Yoav, Vadasz, Zahava, Sabag, Adi D., Tatour, Sameh, Spiegel, Ronen
Publicado 2022

Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

por Itchaki, Gilad, Rokach, Lior, Benjamini, Ohad, Bairey, Osnat, Sabag, Adi, Vernitsky, Helly, Cohen, Hila, Rotem, Shahar, Elia, Uri, Raanani, Pia, Bar-Haim, Erez, Tadmor, Tamar
Publicado 2021